Biggest News Aggregation in the World
📰 Full Data News

Full Data News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Full Data. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

NewAmsterdam Pharma Company B.V.: NewAmsterdam Pharma Presents Full Data from Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe as an Adjunct to High-Intensity Statin Therapy at NLA Scientific Sessions 2023

- Met Primary Endpoint with 63.4% Median Reduction in LDL-C (p - 87.1% of Patients Treated with Combination of Obicetrapib and Ezetimibe Met Guideline-Recommended LDL-C Goal of - New Data Demonstrate
United States Noord Holland Hannah Deresiewicz Christiem Ballantyne Matthew Philippe Company Phase

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science